Top Abstract Purchase Related
Home
>
Node
>
Subnode

Growth factors in chronic hepatitis C

Panasiuk, A.; Pogorzelska, J.; Prokopowicz, D.

Przeglad Epidemiologiczny 61(3): 559-566

2007

ISSN/ISBN: 0033-2100
PMID: 18069394
Document Number: 605753
GROWTH FACTORS: HGF, PDGF, TNF-alpha, IL-6 have important role in liver regeneration. The aim of our study was the evaluation of serum growth factors concentration in chronic hepatitis C. Studied growth factors and cytokines levels were analyzed in relation to inflammatory and fibrotic changes in liver. Seventy-five chronic hepatitis C patients were enrolled in this study. All patients had liver biopsy performed and the microscopic examination of liver tissues were analized according to Scheuer's classification. Serum concentrations of growth factors in patients' serum were assessed by use of ELISA method. The control group consisted of 20 healthy individuals. Serum HGF, PDGF, TNF-alpha level showed significant elevation in the chronic hepatitis C compared to healthy controls. There was a statistically significant correlation between serum HGF and inflammatory activity and fibrosis stage. HGF seems to play an important function during chronic HCV infection.

Document emailed within 1 workday
Secure & encrypted payments

Chen, J.-L.; Wang, L.; Yan, J.; Zhang, L.; Yu, H.; Fan, X.-L. 2007: Predictive factors of hepatitis B virus DNA negative conversion among patients with chronic hepatitis B during lamivudine therapy Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 21(3): 273-275
Tanaka, A.; Lu, J.; Yamanishi, H.; Nonomura, N.; Yasui, T.; Maeyama, M.; Nishizawa, Y.; Matsumoto, K.; Sato, B. 1990: Effects of androgen, fibroblast growth factors or other various growth factors on growth of Shionogi carcinoma cells in a protein-free medium Anticancer Research 10(6): 1637-1641
Lebray, P.; Nalpas, B.; Vallet-Pichard, A.ïs.; Broissand, C.; Sobesky, R.; Serpaggi, J.; Fontaine, H.él.èn.; Pol, S. 2005: The impact of haematopoietic growth factors on the management and efficacy of antiviral treatment in patients with hepatitis C virus Antiviral Therapy 10(6): 769-776
Ouakaa-Kchaou, A.; Gargouri, D.; Kochlef, A.; Debbiche, A.; Elloumi, H.; Ghouma, M.; Kilani, A.; Romani, M.; Kharrat, J.; Ghorbel, A. 2011: Steatosis in chronic hepatitis C: prevalence and predictive factors La Tunisie Medicale 89(11): 830-836
Tassopoulos, N.C.; Papatheodoridis, G.V.; Katsoulidou, A.; Delladetsima, J.K.; Sypsa, V.; Touloumi, G.; Nikandros, M.; Hatzakis, A. 1998: Factors associated with severity and disease progression in chronic hepatitis C Hepato-Gastroenterology 45(23): 1678-1683
López Alonso, G. 1994: Chronic hepatitis C. Predictive factors of response to treatment with interferon Anales de Medicina Interna 11(12): 573-574
Shubina, M.E.; Iakhontova, O.I. 2008: The role of different factors affecting the duodenum in chronic viral hepatitis B Klinicheskaia Meditsina 86(8): 53-56
Wanden-Berghe, C.; Granell, L.; Giménez, J.L.; De Dios Praes, J.; Muñoz-Puller, P.; Cases, C.; Santacruz, N.; González-Valls, T. 2014: Autologous growth factors in the treatment of chronic wounds Revista de Enfermeria 37(5): 51-54
Lo Iacono, O.; DeCastro, M.; Garcia-Buey, L.; Garcia-Monzon, C.; Borque, M.J.; Sanz, P.; Garcia-Sanchez, A.; Moreno-Otero, R. 1998: Epidemiological risk factors and clinico-pathological presentation in chronic hepatitis C Hepato-Gastroenterology 45(23): 1715-1721
Ishibashi, K.; Kashiwagi, T.; Ito, A.; Tanaka, Y.; Nagata, T.; Tamaki, J.; Azuma, M.; Kishida, Y.; Yoshida, A.; Hikiji, A.Y. 1995: Predictive factors for efficacy of interferon therapy in chronic hepatitis type C Hepato-Gastroenterology 42(5): 535-541
Elloumi, H.él.; Hefaiedh, R.; Gargouri, D.; Chedly-Debbiche, A.; Khayat, O.; Bel Hadj, N.; Kharrat, J.; Ghorbel, A. 2008: Hepatic steatosis in chronic hepatitis B: contributing factors and effect on fibrosis La Tunisie Medicale 86(11): 1000-1003
Guo, J.-C.; Ma, X.-H.; Xun, Y.-H.; Xiao, L.-N.; Shi, W.-Z.; Shi, J.-P.; Wang, W.-W.; Lou, G.-Q. 2011: P53 expression in liver tissue of patients with chronic hepatitis B and its influencing factors Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 25(5): 322-324
Paul, D. 1985: Growth factors, oncogenes and transformation. Part I: Growth factors and cell cycle control Arzneimittel-Forschung 35(4): 772-779
Sonnabend, W.; Kistler, G.S.; Thiel, G.; Zollinger, H.U.; Bianchi, L.; Enderlin, F.; Gudat, F.; Krech, U. 1974: Chronic focal glomerulonephritis and chronic persistent hepatitis following kidney transplantation. Detection of Hepatitis B and Epstein-Barr virus antigen Schweizerische Medizinische Wochenschrift 104(35): 1205-1217
Pirotte, J.; Rauber, G.; Ruyters, L. 1972: Chronic persistent hepatitis and chronic active hepatitis. Correlations between the histological aspects, clinical picture, biological and immunological data Archives Francaises des Maladies de l'Appareil Digestif 61(1): 7-18
Korba, B.E.; Cote, P.J.; Menne, S.; Toshkov, I.; Baldwin, B.H.; Wells, F.V.; Tennant, B.C.; Gerin, J.L. 2004: Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection Antiviral Therapy 9(6): 937-952
Selivestrova, T.R.; Trufanova, I.M.; Morozov, S.V.; Isakov, V.A. 2011: Indicators of body composition as prognostic factors of efficiency of antiviral therapy for chronic hepatitis C Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 54-58
Kokoreva, L.N.; Zmyzgova, A.V.; Shalygina, N.B. 1996: The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results Terapevticheskii Arkhiv 68(2): 10-14
Ma, L.-n.; Chen, X.-y.; Chen, J.; Shen, C.-l.; Wang, J.-t. 2006: Efficacy, influencing factors and safety of PEG-INF alpha-2a (PEG-INF-2a) in the treatment of chronic hepatitis C: analysis of 89 patients Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 20(2): 42-45
Rodríguez, A.; Castaño, M.; Peña, L.; Sánchez, M.A.; Nieto, A.; Rodríguez, M. 1996: Immunocytochemical detection of growth factors (PDGF and TGF beta) in equine chronic pneumonia Research in Veterinary Science 60(1): 82-87